Creative Biolabs is set to host a webinar titled "Modeling T Cell Dysfunction in Tumor Microenvironments" on September 1, 2026, at 10:00 AM EDT. The live virtual event will feature Greg M. Delgoffe, Ph.D., Professor of Immunology at the University of Pittsburgh and Director of the Tumor Microenvironment Center at the UPMC Hillman Cancer Center. This webinar aims to address the critical challenges posed by the tumor microenvironment (TME) in cancer treatment.
The TME is a complex ecosystem where cancer cells, immune cells, and metabolites interact, often creating a metabolically hostile environment characterized by nutrient depletion and immunosuppressive byproducts. These conditions impair immune cell function, leading to T cell dysfunction and immune evasion, which ultimately reduce the efficacy of standard cancer immunotherapies. Understanding these mechanisms is vital for developing more effective treatments.
Dr. Delgoffe will discuss innovative approaches to model these intricate environments. Traditional models often fail to capture the nuanced interactions between tumor metabolism and immune regulation. By leveraging advanced preclinical testing services and robust in vivo and in vitro models, researchers can better replicate metabolic stress conditions. These systems provide valuable tools to investigate immune suppression and therapeutic responses under physiologically relevant conditions, offering insights that could translate into improved clinical outcomes.
"Understanding how metabolic conditions within tumors influence immune-cell behavior is increasingly important in immuno-oncology," said a senior scientific director at Creative Biolabs. "Dr. Delgoffe's work provides an important perspective on how researchers can model these conditions and investigate target discovery and validation."
Key highlights of the webinar include an exploration of how tumor metabolic environments contribute to immune suppression and T cell exhaustion, strategies for modeling TME conditions in preclinical research systems, the mechanisms underlying T cell exhaustion and the influence of nutrient depletion on T cell function, and how immunometabolism insights can guide therapeutic strategies to enhance cancer immunotherapy.
This webinar is particularly relevant for cancer immunology researchers, pharmaceutical and biotechnology professionals, and R&D teams dedicated to oncology drug discovery. Attendees will gain a deeper understanding of the metabolic barriers to effective immunotherapy and how to model them in preclinical settings.
For webinar details and registration, please visit https://www.creative-biolabs.com/immuno-oncology/webinar-modeling-t-cell-dysfunction-tumor-microenvironments.htm.
